版本:
中国

BRIEF-Urogen Pharma announces agreement to license RTGEL for use with Neurotoxins to Allergan

Oct 14 Allergan Plc :

* Press release - Urogen Pharma announces agreement to license RTGEL for use with Neurotoxins to Allergan

* Urogen Pharma - Allergan to make upfront payment of $17.5 million, as well as potential development and commercial milestones and royalties on net sales Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐